Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 13:11:318.
doi: 10.3389/fncel.2017.00318. eCollection 2017.

Targeting WNT Signaling for Multifaceted Glioblastoma Therapy

Affiliations
Review

Targeting WNT Signaling for Multifaceted Glioblastoma Therapy

Matthew McCord et al. Front Cell Neurosci. .

Abstract

The WNT signaling pathway has been of great interest to developmental biologists for decades and has more recently become a central topic for study in cancer biology. It is vital for cell growth and regulation of embryogenesis in many organ systems, particularly the CNS and its associated vasculature. We summarize the role of WNT in CNS development and describe how WNT signaling makes key contributions to malignant glioma stemness, invasiveness, therapeutic resistance, and angiogenesis. The role of WNT in these mechanisms, along with creation and maintainance of the blood-brain barrier (BBB), points to the potential of WNT as a multi-faceted target in malignant glioma therapy.

Keywords: WNT; angiogenesis; cancer biology; drug delivery; glioblastoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of WNT signaling pathway activation. (Left) WNT signaling inactivation with absence of the WNT ligand. Phosphorylation of β-catenin resulted in Dishevelled (DVL), Axin, APC and GSK3β complex resulting in proteosomal degradation. (Right) Canonical WNT signaling activation after WNT ligand binding. Unphosphorylated β-catenin enters the nucleus to drive transcription affecting such genes as C-MYC, SOX9, CD44.
Figure 2
Figure 2
Potential benefits of inhibiting WNT signaling. (A) WNT inhibition blocking innate features of tumor biology could decrease tumor cell stemness, prevent tumor invasiveness and decrease therapeutic resistance. (B) Inhibition impacts glioblastoma vasculature by blocking angiogenesis. (C) Signaling inhibition results in increased BBB permeability allowing for improved chemotherapy delivery.

References

    1. Anderson K. D., Pan L., Yang X. M., Hughes V. C., Walls J. R., Dominguez M. G., et al. . (2011). Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 108, 2807–2812. 10.1073/pnas.1019761108 - DOI - PMC - PubMed
    1. Auger N., Thillet J., Wanherdrick K., Idbaih A., Legrier M. E., Dutrillaux B., et al. . (2006). Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line. Mol. Cancer Ther. 5, 2182–2192. 10.1158/1535-7163.MCT-05-0428 - DOI - PubMed
    1. Baryawno N., Sveinbjornsson B., Eksborg S., Chen C. S., Kogner P., Johnsen J. I. (2010). Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res. 70, 266–276. 10.1158/0008-5472.CAN-09-0578 - DOI - PubMed
    1. Bautch V. L., James J. M. (2009). Neurovascular development: the beginning of a beautiful friendship. Cell Adh. Migr. 3, 199–204. 10.4161/cam.3.2.8397 - DOI - PMC - PubMed
    1. Bhatt P. M., Malgor R. (2014). Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis 237, 155–162. 10.1016/j.atherosclerosis.2014.08.027 - DOI - PMC - PubMed